COLUMBIA, S.C. – October 28, 2011 – Nephron Pharmaceuticals Corporation today announced that the company will locate its new operations in Lexington County. The $313 million investment is expected to generate 707 new jobs.
“We are excited to expand our company by locating our new manufacturing facility in Lexington County. This is a big step for our firm and will help us meet increased demand, expand our market share and develop our pipeline of products. South Carolina has an excellent business environment and we look forward to our expansion into the Palmetto State,” said Lou Kennedy, CEO of Nephron Pharmaceuticals Corporation.
Nephron Pharmaceuticals Corporation will establish a new pharmaceutical manufacturing campus and offices in Lexington County. The company is based in Orlando where it currently operates 250,000 square feet of manufacturing, distribution and packaging facilities. Additionally, the company has distribution centers in Kentucky and Arizona.
“It’s another great day in South Carolina with today’s announcement. We celebrate Nephron Pharmaceuticals’ decision to locate its new manufacturing facility in the Midlands and create hundreds of well-paying new jobs. This is a big win for our state,” said Gov. Nikki Haley.
In June, William and Lou Kennedy were awarded the Order of the Palmetto for their philanthropy in founding the Kennedy School of Pharmacy at the University of South Carolina. Both are South Carolinians and alumni of the University of South Carolina. Discussions between the Governor and the Kennedys during the Order of the Palmetto visit led the company to consider South Carolina for the new facility.
“I am gratified that Lou and Bill Kennedy, who have already established the Kennedy Pharmacy Innovation Center at Innovista, see the University of South Carolina and our state as locations to further their commitment to pharmaceutical manufacturing with world class quality and efficiency. Their vision and keen business acumen have led to an important second step in increasing innovation and the knowledge economy in South Carolina,” said Dr. Harris Pastides, USC president.
“Nephron Pharmaceuticals’ investment and new jobs will have a huge positive impact on our state. This new facility will be a major boost for our pharmaceutical manufacturing sector. Today’s announcement is the largest one in the state’s life sciences industry this year,” said Bobby Hitt, Secretary of Commerce.
The new facility will be located on a 60-acre parcel of land near the Amazon facility in Lexington. It is expected to be up and running in the next couple of years.
“I would like to take this opportunity to publically recognize and celebrate the remarkable achievements of Nephron Pharmaceuticals and to hail their decision to expand their operations into their ‘home’ state. This expansion will bring over $313 million dollars into our local economy and will generate more than 700 jobs for the citizens of Lexington County, the Midlands and South Carolina. Nephron Pharmaceuticals Corporation is a
renowned leader in its field, and through the years has grown to manufacture over one billion units of medication. What an accomplishment,” said Lexington County Council Chairman Jim Kinard.
Central SC Alliance Chairman Jim Apple said, “Today’s significant capital investment and high-wage job creation announcement by Nephron Pharmaceuticals Corporation is a game changer in our quest to recruit international life science/biotechnology industries to the Central South Carolina region. This company is a market leader that produces millions of units of life-saving medications every year right here in the United States and shortly, product will be coming out of Lexington County. We want to recognize and thank the Kennedys for coming back home to South Carolina in making this announcement. The Central SC Alliance is proud to represent a dynamic nine-county region and we value the outstanding working relationship with the University of South Carolina and the S.C. Department of Commerce as we collectively grow our region.”
The S.C. Department of Commerce has committed a set aside grant of $4.5 million for site preparation and infrastructure. The company was also approved for job development credits, which will be available when hiring targets are met. The company will receive training support from the state’s ReadySC program.
Nephron Pharmaceuticals Corporation is a global leader in manufacturing generic respiratory medications. The company’s products are available to retail pharmacies, hospitals, home care companies, long term care facilities, mail order pharmacies, and various other customers. For more information about Nephron Pharmaceuticals Corporation, please visit www.nephronpharm.com.